pharma · Chronic Hepatitis Delta Virus Infection · Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Huahui Health
Huahui Health is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Hepatitis Delta Virus Infection, Advanced or Unresectable Hepatocellular Carcinoma (HCC). NovaPharmaNews links 2
Changping, CN HQ
3 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Changping, CN
- Employees
- 3
- Programs
- 2
- Drugs
- 2
- Patents
- 0
HH-003(20mg/kg)
Phase 2 · mab · Chronic Hepatitis Delta Virus Infection
HH-003(20mg/kg) for Chronic Hepatitis Delta Virus Infection is a Phase 2 program (mab) at Huahui Health with 1 ClinicalTrials.gov record(s).
Internal code HH003-204
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Huahui Health
- Phase
- Phase 2
- Modality
- mab
- Indication
- Chronic Hepatitis Delta Virus Infection
- Status
- completed
- Trials
- 1